Home » Topics » Disease categories and therapies » Infection

Infection
RSS

ChemGenics/Wyeth-Ayerst antibacterial drug discovery collaboration

Dec. 6, 1996

New azole antifungal agents described by Zambon

Dec. 4, 1996

New treatment options improve outlook for patients with viral skin infections

Dec. 3, 1996

Lidak reacquires certain rights to Lidakol from BMS

Dec. 2, 1996

Ivermectin approved for use in humans

Dec. 2, 1996

Merck & Co. describes lipid A biosynthesis inhibitor with antibacterial activity

Dec. 2, 1996

Frog peptides with antimicrobial activity available for licensing

Dec. 2, 1996

Antimicrobial peptide combinations available for licensing

Dec. 2, 1996

Takeda describes antiprotozoal agents

Nov. 29, 1996

Antimicrobial ranalexin peptides available for licensing

Nov. 28, 1996

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 15, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 16, 2025.
Apollo’s APL-4098 shows potent antileukemic effects
BioWorld Science
Apollo Therapeutics Ltd. has developed APL-4098, a small-molecule general control nonderepressible 2 (GCN2) inhibitor for the potential treatment of AML.
CTAD 2025: Diagnosing semaglutide’s failure in Alzheimer’s trials
BioWorld
A little over a week after announcing that the Evoke and Evoke+ studies failed to show that oral semaglutide could slow cognition decline in patients with...
FDA greenlights Medtronic Onyx subdural hematoma treatment
BioWorld MedTech
Sometimes the darkest products (names) bring a bright spot of news to their developers, as the U.S. FDA clearance for Galway, Ireland-based Medtronic plc's Onyx...